I told you to stop: obscurin's role in epithelial cell migration.
Kamrin D ShultzYasmin F Al AnbariNathan T WrightPublished in: Biochemical Society transactions (2024)
The giant cytoskeletal protein obscurin contains multiple cell signaling domains that influence cell migration. Here, we follow each of these pathways, examine how these pathways modulate epithelial cell migration, and discuss the cross-talk between these pathways. Specifically, obscurin uses its PH domain to inhibit phosphoinositide-3-kinase (PI3K)-dependent migration and its RhoGEF domain to activate RhoA and slow cell migration. While obscurin's effect on the PI3K pathway agrees with the literature, obscurin's effect on the RhoA pathway runs counter to most other RhoA effectors, whose activation tends to lead to enhanced motility. Obscurin also phosphorylates cadherins, and this may also influence cell motility. When taken together, obscurin's ability to modulate three independent cell migration pathways is likely why obscurin knockout cells experience enhanced epithelial to mesenchymal transition, and why obscurin is a frequently mutated gene in several types of cancer.
Keyphrases
- cell migration
- single cell
- systematic review
- squamous cell carcinoma
- induced apoptosis
- cell therapy
- stem cells
- biofilm formation
- gene expression
- escherichia coli
- pseudomonas aeruginosa
- young adults
- mesenchymal stem cells
- bone marrow
- cell death
- copy number
- genome wide
- cell proliferation
- small molecule
- endoplasmic reticulum stress
- smooth muscle
- lymph node metastasis